Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Date of authorisation: 14/08/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 6, Status: Authorised
Regulatory Procedure Management in IRIS roadmap
Minutes of the PRAC meeting 29 September - 2 October 2025
Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 October 2025
Minutes of the HMPC meeting 22-24 September 2025
Antimicrobial resistance
Antimicrobial resistance – Act Now: Protect our present, secure our future
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 33, Status: Authorised